GSI Technology, Inc. Reports Second-Quarter Fiscal 2018

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
110
GSI Technology, Inc. Reports Second-Quarter Fiscal 2018 Results

SUNNYVALE, CA--(Marketwired - Oct 26, 2017) -   GSI Technology, Inc. ( NASDAQ : GSIT ) today reported financial results for its second fiscal quarter ended September 30, 2017.

The Company reported a net loss of $(1.7 million), or $(0.08) per diluted share, on net revenues of $9.6 million for the second quarter of fiscal 2018, compared to net income of $626,000, or $0.03 per diluted share, on net revenues of $13.4 million for the second quarter of fiscal 2017 and a net loss of $(1.5 million), or $(0.07) per diluted share, on net revenues of $10.7 million for the first quarter of fiscal 2018, ended June 30, 2017. Gross margin was 50.4% compared to 55.0% in the prior year period and 52.4% in the first quarter.

Total operating expenses in the second quarter of fiscal 2018 were $6.7 million, compared to $7.0 million in the second quarter of fiscal 2017 and $7.1 million in the preceding first quarter. Research and development expenses were $4.2 million, compared to $4.3 million in the prior year period and $4.3 million in the preceding quarter. Selling, general and administrative expenses were comparable year-over-year at $2.5 million compared to $2.7 million in the quarter ended September 30, 2016, and down sequentially from $2.8 million in the preceding quarter.

Lee-Lean Shu, Chairman and Chief Executive Officer, noted, "Our net revenues and gross margin came below the range of guidance that we provided earlier in the second quarter. During the period, we continued to see slowness in our primary telecommunications and networking markets. We are excited about our product development and marketing efforts for our newest market segments, which are our high performance SigmaQuad radiation-hardened SRAM products targeted at aerospace and defense applications and our patented in-place associative computing technology, or 'APU'. We remain on schedule to complete the design of our initial APU product by the end of January 2018."

"At the recent In-Memory Computing summit, we presented how the APU is well suited to Natural Language Processing (NLP). We were also recently invited to make a technical presentation on the APU at one of the leading aerospace research and development centers and were also invited to present the APU architecture at Stanford University as part of their EE Computer Systems Colloquium (EE380)."

"We now have packaged parts of our SigmaQuad radiation hardened SRAM product. Once we finish processing these parts, they will be available to ship as revenue generating samples during the third quarter of fiscal 2018. Starting this week, we are beginning the qualification process for our MIL-PRS-38535 Class V equivalent product for shipments in calendar 2018."

In the second quarter of fiscal 2018, sales to Nokia (Alcatel-Lucent) were $2.8 million, or 29.0% of net revenues compared to $4.5 million, or 42.3% of net revenues, in the prior quarter and $5.7 million, or 42.8% of net revenues, in the same period a year ago. Direct and indirect sales to Cisco Systems were $506,000 or 5.2% of net revenues, compared to $852,000, or 8.0% of net revenues, in the prior quarter, and $936,000, or 7.0% of net revenues, in the same period a year ago. Military/defense sales were 24.4% of shipments compared to 24.5% of shipments in the prior quarter and 16.1% of shipments in the comparable period a year ago. SigmaQuad sales were 39.4% of shipments compared to 51.1% in the prior quarter and 57.2% in the second quarter of fiscal 2017.

Second-quarter fiscal 2018 operating loss was $(1.8 million), compared to an operating loss of $(1.5 million) in the prior quarter and operating income of $380,000 a year ago. Second-quarter fiscal 2018 net income included interest and other income of $103,000 and a tax provision of $49,000, compared to $92,000 in interest and other income and a tax benefit of $154,000 a year ago; in the preceding quarter, net loss included interest and other income of $98,000 and a tax provision of $81,000.

Total second-quarter pre-tax stock-based compensation expense was $508,000 compared to $478,000 in the prior quarter and $487,000 in the comparable quarter a year ago.

At September 30, 2017, the Company had $49.6 million in cash, cash equivalents and short-term investments, $14.6 million in long-term investments, $56.3 million in working capital, no debt, and stockholders' equity of $85.6 million.

Outlook for Third Quarter of Fiscal 2018

For the third quarter of fiscal 2018, we currently expect net revenues to be in the range of $10.0 million to $11.0 million, with gross margin in a range of 53% to 55%.

Conference Call

GSI Technology will review its financial results for the quarter ended September 30, 2017 and discuss its current business outlook during a conference call at 1:30 p.m. Pacific (4:30 p.m. Eastern) today, October 26, 2017. To participate in the teleconference, please call toll-free 888-503-8177 approximately 10 minutes prior to the above start time and provide Conference ID 6861679. You may also listen to the teleconference live via the Internet at www.gsitechnology.com , where it will be archived.

About GSI Technology

Founded in 1995, GSI Technology, Inc. is a provider of high performance semiconductor memory solutions to networking, industrial, medical, aerospace and military customers. The company is headquartered in Sunnyvale, California and has sales offices in the Americas, Europe and Asia. For more information, please visit www.gsitechnology.com .

Forward-Looking Statements

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding GSI Technology's expectations, beliefs, intentions, or strategies regarding the future. All forward-looking statements included in this press release are based upon information available to GSI Technology as of the date hereof, and GSI Technology assumes no obligation to update any such forward-looking statements. Forward-looking statements involve a variety of risks and uncertainties, which could cause actual results to differ materially from those projected. These risks include those associated with the normal quarterly closing process. Examples of risks that could affect our current expectations regarding third quarter revenues and gross margins include those associated with fluctuations in GSI Technology's operating results; GSI Technology's historical dependence on sales to a limited number of customers and fluctuations in the mix of customers and products in any period; the rapidly evolving markets for GSI Technology's products and uncertainty regarding the development of these markets; the need to develop and introduce new products to offset the historical decline in the average unit selling price of GSI Technology's products; the challenges of rapid growth followed by periods of contraction; and intensive competition; and delays or unanticipated costs that may be encountered in the development of new products based on our in-place associative computing technology and the establishment of new markets and customer relationships for the sale of such products. Further information regarding these and other risks relating to GSI Technology's business is contained in the Company's filings with the Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" in such filings.

 
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(Unaudited)
                             
    Three Months Ended     Six Months Ended
    Sept. 30,     June 30,     Sept. 30,     Sept. 30,     Sept. 30,
    2017     2017     2016     2017     2016
                             
Net revenues   $ 9,647     $ 10,687     $ 13,358     $ 20,334     $ 26,304
Cost of goods sold     4,789       5,083       6,015       9,872       12,239
                                       
Gross profit     4,858       5,604       7,343       10,462       14,065
                                       
Operating expenses:                                      
                                       
  Research & development     4,160       4,335       4,282       8,495       7,781
  Selling, general and administrative     2,492       2,798       2,681       5,290       5,515
    Total operating expenses     6,652       7,133       6,963       13,785       13,296
                                       
Operating income (loss)     (1,794 )     (1,529 )     380       (3,323 )     769
                                       
Interest and other income (expense), net     103       98       92       201       234
                                       
Income (loss) before income taxes     (1,691 )     (1,431 )     472       (3,122 )     1,003
Provision (benefit) for income taxes     49       81       (154 )     130       117
Net income (loss)   $ (1,740 )   $ (1,512 )   $ 626     $ (3,252 )   $ 886
                                       
                                       
Net income (loss) per share, basic   $ (0.08 )   $ (0.07 )   $ 0.03     $ (0.16 )   $ 0.04
Net income (loss) per share, diluted   $ (0.08 )   $ (0.07 )   $ 0.03     $ (0.16 )   $ 0.04
                                       
Weighted-average shares used in computing per share amounts:                                      
                                       
Basic     21,037       20,805       20,529       20,922       20,912
Diluted     21,037       20,805       21,104       20,922       21,349
                                       
                             
Stock-based compensation included in the Condensed Consolidated Statements of Operations:   
                             
    Three Months Ended     Six Months Ended
    Sept. 30,     June 30,     Sept. 30,     Sept. 30,     Sept. 30,
    2017     2017     2016     2017     2016
                                       
Cost of goods sold   $ 66     $ 47     $ 79     $ 113     $ 172
Research & development     284       267       238       551       420
Selling, general and administrative     158       164       170       322       338
    $ 508     $ 478     $ 487     $ 986     $ 930
                                       
                             
Litigation related expenses included in the Condensed Consolidated Statements of Operations:   
                             
    Three Months Ended     Six Months Ended
    Sept. 30,     June 30,     Sept. 30,     Sept. 30,     Sept. 30,
    2017     2017     2016     2017     2016
                                       
Selling, general and administrative   $ 1     $ 50     $ 47     $ 54     $ 53
 
 
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(Unaudited)
         
    Sept. 30, 2017   March 31, 2017
Cash and cash equivalents   $ 37,438   $ 33,736
Short-term investments     12,203     16,199
Accounts receivable     5,352     6,349
Inventory     8,474     9,211
Other current assets     2,410     2,777
Net property and equipment     7,595     7,689
Long-term investments     14,596     12,898
Other assets     13,024     13,736
Total assets   $ 101,092   $ 102,595
             
Current liabilities   $ 9,559   $ 10,474
Long-term liabilities     5,886     5,677
Stockholders' equity     85,647     86,444
Total liabilities and stockholders' equity   $ 101,092   $ 102,595
             

GSI Technology, Inc. Douglas M. Schirle Chief Financial Officer 408-331-9802 Hayden IR David Fore or Brett Maas 206-395-2711

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 72

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 168

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Jade Power Trust Celebrates Success at Annual and Special Meeting

Updated Category News Views 190

Jade Power Trust's Annual Meeting Highlights Jade Power Trust (TSXV: JPWR.H) recently concluded its Annual and Special Meeting of unitholders, where significant decisions were made to shape the future of the Trust. The meeting, organized with great attention and resources, took place with a focus on transparency and community engagement. Re-election of Board Members...

Continue Reading
Vesper Bio's Breakthrough Phase I Results for FTD Treatment

Updated Category News Views 112

Vesper Bio Reports Positive Results from Phase I Study Vesper Bio ApS, a biotech company in the clinical stage known for its advancements in sortilin receptor biology, has made significant strides with its lead candidate, VES001. This groundbreaking compound is emerging as a potentially disease-modifying treatment for patients diagnosed with frontotemporal dementia (FTD),...

Continue Reading
Texas Pacific Land Trust Achieves Record Stock Performance

Updated Category News Views 103

Texas Pacific Land Trust Reaches New Heights In a significant display of market strength, Texas Pacific Land Trust (NYSE: TPL) stock has soared to an extraordinary all-time high of $996.82. This remarkable feat highlights a period of impressive growth for the company, as its stock has demonstrated a stunning 63.04% increase over the past year. Investors are exhibiting...

Continue Reading
Headwall Photonics Partners with NV5 to Enhance ENVI Software

Updated Category News Views 77

Headwall Photonics scored a major win back in 2024, announcing a strategic partnership with NV5 that aimed to shake up the hyperspectral imaging landscape. The deal wasn’t just about another tech tie-up; it was about embedding NV5's renowned ENVI software into Headwall's offerings, which could change how users handle geospatial data. ENVI Software Integration: What’s...

Continue Reading
DZS Inc. Completes Strategic Asset Sale to AXON Networks

Updated Category News Views 222

DZS Inc. Completes Strategic Asset Sale DZS Inc. (OTC: DZSI), known for its advanced network edge, connectivity, and cloud edge software solutions, has successfully completed the sale of its service assurance and WiFi management software portfolio to AXON Networks. This transaction includes key products such as Expresse, CloudCheck, and TruSpeed, along with their...

Continue Reading